Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sesmu M. Arbous"'
Autor:
Krista E. van Meijgaarden, Suzanne van Veen, Roula Tsonaka, Paula Ruibal, Anna H. E. Roukens, Sesmu M. Arbous, Judith Manniën, Suzanne C. Cannegieter, Tom H. M. Ottenhoff, Simone A. Joosten, BEAT-COVID group, COVID-19 LUMC group
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract SARS-CoV2 infection results in a range of disease severities, but the underlying differential pathogenesis is still not completely understood. At presentation it remains difficult to estimate and predict severity, in particular, identify ind
Externí odkaz:
https://doaj.org/article/ec8abf5677584e6393f7d726ab558093
Autor:
Marco R. Bladergroen, Tamas Pongracz, Wenjun Wang, Simone Nicolardi, Sesmu M. Arbous, Anna Roukens, Manfred Wuhrer
Publikováno v:
iScience, Vol 27, Iss 7, Pp 110374- (2024)
Summary: Total plasma protein N-glycosylation (TPNG) changes are a hallmark of many diseases. Here, we analyzed the TPNG of 169 COVID-19 patients and 12 healthy controls, using mass spectrometry, resulting in the relative quantification of 85 N-glyca
Externí odkaz:
https://doaj.org/article/361a6771232c499a9447afbc045d63f3
Autor:
Emiel Leegwater, Lisa Dol, Menno R. Benard, Eveline E. Roelofsen, Nathalie M. Delfos, Machteld van der Feltz, Femke P. N. Mollema, Liesbeth B. E. Bosma, Loes E. Visser, Thomas H. Ottens, Nathalie D. van Burgel, Sesmu M. Arbous, Lahssan H. El Bouazzaoui, Rachel Knevel, Rolf H. H. Groenwold, Mark G. J. de Boer, Leo G. Visser, Frits R. Rosendaal, Erik B. Wilms, Cees van Nieuwkoop
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 10, Pp 2471-2484 (2023)
Abstract Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19 that has moderate clinical effectiveness. Anecdotally, some patients’ respiratory insufficiency seemed to recover particularly rapidly after initiati
Externí odkaz:
https://doaj.org/article/17449ed6f2c14287ad8e56894159692a
Autor:
Meryem Baysan, Mark Broere, Maarten E. Wille, Jule E. Bergsma, Egbert G. Mik, Nicole P. Juffermans, Roula Tsonaka, Johanna G. van der Bom, Sesmu M. Arbous
Publikováno v:
PLoS ONE, Vol 19, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/ef254cdc9ad342ad92ea927276626f18
Autor:
Jim M. Smit, Jesse H. Krijthe, Andrei N. Tintu, Henrik Endeman, Jeroen Ludikhuize, Michel E. van Genderen, Shermarke Hassan, Rachida El Moussaoui, Peter E. Westerweel, Robbert J. Goekoop, Geeke Waverijn, Tim Verheijen, Jan G. den Hollander, Mark G. J. de Boer, Diederik A. M. P. J. Gommers, Robin van der Vlies, Mark Schellings, Regina A. Carels, Cees van Nieuwkoop, Sesmu M. Arbous, Jasper van Bommel, Rachel Knevel, Yolanda B. de Rijke, Marcel J. T. Reinders
Publikováno v:
Intensive Care Medicine Experimental, Vol 10, Iss 1, Pp 1-18 (2022)
Abstract Background Timely identification of deteriorating COVID-19 patients is needed to guide changes in clinical management and admission to intensive care units (ICUs). There is significant concern that widely used Early warning scores (EWSs) und
Externí odkaz:
https://doaj.org/article/adac0ffa1c414d52b8915466386d496a
Autor:
Tamas Pongracz, Jan Nouta, Wenjun Wang, Krista E. van Meijgaarden, Federica Linty, Gestur Vidarsson, Simone A. Joosten, Tom H.M. Ottenhoff, Cornelis H. Hokke, Jutte J.C. de Vries, Sesmu M. Arbous, Anna H.E. Roukens, Manfred Wuhrer
Publikováno v:
EBioMedicine, Vol 78, Iss , Pp 103957- (2022)
Summary: Background: Immunoglobulin G1 (IgG1) effector functions are impacted by the structure of fragment crystallizable (Fc) tail-linked N-glycans. Low fucosylation levels on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) pr
Externí odkaz:
https://doaj.org/article/d1d4814281ce4ec7ba68913c86f07a78
Autor:
Judith van Paassen, Jeroen S. Vos, Eva M. Hoekstra, Katinka M. I. Neumann, Pauline C. Boot, Sesmu M. Arbous
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-22 (2020)
Abstract Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring
Externí odkaz:
https://doaj.org/article/a04811acf11f43b98bd6c074b5ab3110
Autor:
Mihaela Zlei, Igor A. Sidorov, Simone A. Joosten, Mirjam H. M. Heemskerk, Sebenzile K. Myeni, Cilia R. Pothast, Caroline S. de Brouwer, A. Linda Boomaars-van der Zanden, Krista E. van Meijgaarden, Shessy T. Morales, Els Wessels, Jacqueline J. Janse, Jelle J. Goeman, Christa M. Cobbaert, Aloys C. M. Kroes, Suzanne C. Cannegieter, Meta Roestenberg, Leonardus G. Visser, Marjolein Kikkert, Mariet C. W. Feltkamp, Sesmu M. Arbous, Frank J. T. Staal, Tom H. M. Ottenhoff, Jacques J. M. van Dongen, Anna H. E. Roukens, Jutte J. C. de Vries, in collaboration with BEAT-COVID, in collaboration with LUMC COVID
Publikováno v:
Cells, Vol 11, Iss 17, p 2743 (2022)
Virus-specific cellular and humoral responses are major determinants for protection from critical illness after SARS-CoV-2 infection. However, the magnitude of the contribution of each of the components to viral clearance remains unclear. Here, we st
Externí odkaz:
https://doaj.org/article/70065a3824ce4890ba8d4a1f3bff6993
Autor:
Bashar N. Hilderink, Reinier F. Crane, Meryem Baysan, Sesmu M. Arbous, Bas van den Bogaard, Egbert G. Mik, Can Ince, Janesh Pillay, Nicole P. Juffermans
Publikováno v:
Journal of Applied Physiology. 134:1165-1176
This is the first paper to simulate mitochondrial oxygen tension in skin in circulatory shock. The relationships of mitoPo2 with parameters of (microcirculatory) oxygen delivery aid in the understanding of noninvasive bedside measurement of mitoPo2 v
Autor:
Pieter-Roel Tuinman, Niels van Mourik, Olaf L. Cremer, Anna-Linda Peters, Hendrik Endeman, Robert B. Klanderman, Rob J. Bosman, Alexander P.J. Vlaar, Dorus Eggermont, Sesmu M Arbous
Publikováno v:
Transfusion, 62(9), 1752-1762. Wiley-Blackwell
Klanderman, R B, van Mourik, N, Eggermont, D, Peters, A-L, Tuinman, P R, Bosman, R, Endeman, H, Cremer, O L, Arbous, S M & Vlaar, A P J 2022, ' Incidence of transfusion-related acute lung injury temporally associated with solvent/detergent plasma use in the ICU : A retrospective before and after implementation study ', Transfusion, vol. 62, no. 9, pp. 1752-1762 . https://doi.org/10.1111/trf.17049
Klanderman, R B, van Mourik, N, Eggermont, D, Peters, A-L, Tuinman, P R, Bosman, R, Endeman, H, Cremer, O L, Arbous, S M & Vlaar, A P J 2022, ' Incidence of transfusion-related acute lung injury temporally associated with solvent/detergent plasma use in the ICU : A retrospective before and after implementation study ', Transfusion, vol. 62, no. 9, pp. 1752-1762 . https://doi.org/10.1111/trf.17049
Background: Transfusion-related acute lung injury (TRALI) is a severe complication of plasma transfusion, though use of solvent/detergent pooled plasma (SDP) has nearly eliminated reported TRALI cases. The goal of this study was to investigate TRALI